KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Cash & Equivalents (2019 - 2025)

Ginkgo Bioworks Holdings filings provide 7 years of Cash & Equivalents readings, the most recent being $167.2 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 70.23% to $167.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $167.2 million, a 70.23% decrease, with the full-year FY2025 number at $167.2 million, down 70.23% from a year prior.
  • Cash & Equivalents hit $167.2 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $111.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.7 billion in Q3 2021 to a low of $111.1 million in Q3 2025.
  • Median Cash & Equivalents over the past 5 years was $892.3 million (2023), compared with a mean of $858.5 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 483.8% in 2022 and later plummeted 81.98% in 2025.
  • Ginkgo Bioworks Holdings' Cash & Equivalents stood at $1.6 billion in 2021, then fell by 15.11% to $1.3 billion in 2022, then fell by 28.25% to $944.1 million in 2023, then plummeted by 40.52% to $561.6 million in 2024, then plummeted by 70.23% to $167.2 million in 2025.
  • The last three reported values for Cash & Equivalents were $167.2 million (Q4 2025), $111.1 million (Q3 2025), and $203.6 million (Q2 2025) per Business Quant data.